Cambridge Antibody - Blocklisting Interim Review

RNS No 1293a
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC


      ** B L O C K L I S T I N G  S I X  M O N T H L Y  R E V I E W  **
         **********************************************************
                   

1.  NAME OF COMPANY:          CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

2.  NAME OF SCHEME:           CAMBRIDGE ANTIBODY TECHNOLOGY SHARE OPTION SCHEME

3.  PERIOD OF RETURN:         FROM: 1 OCTOBER 1998   TO: 31 MARCH 1999

4.  NUMBER AND CLASS OF SHARES(S)
    (AMOUNT OF STOCK/DEBT SECURITY)     2,123,215  10P ORDINARY SHARES
    NOT ISSUED UNDER SCHEME
    AT END OF THE LAST PERIOD:

5.  NUMBER OF SHARES ISSUED/ALLOTTED
    UNDER SCHEME DURING PERIOD:         437,500

6.  BALANCE UNDER SCHEME  NOT YET 
    ISSUED/ALLOTTED AT END OF PERIOD:   1,685,715

7.  NUMBER AND CLASS OF SHARE(S)
    (AMOUNT OF STOCK/DEBT SECURITIES)   22,136,251   10P ORDINARY SHARES
    ORIGINALLY LISTED AND THE DATE      25 MARCH 1997
    OF ADMISSION:

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE
AT THE END OF THE PERIOD IN ORDER FOR US TO       23,981,634
UPDATE OUR RECORDS.                               10P ORDINARY SHARES

CONTACT FOR QUERIES:                             

NAME: MISS DIANE MELLETT

TELEPHONE: [phone]


END


BLREFFFBKZKEBKX